Walleye Capital
APRE icon

Walleye Capital’s Aprea Therapeutics APRE Stock Holding History

Walleye Capital’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80,000
Closed -$376K – 5402
2023
Q4 		$376K Sell
80,000
-2,356
-3% -$9.64K 0.01% 3167
2023
Q3 		$345K Sell
82,356
-11,271
-12% -$41.1K 0.01% 3118
2023
Q2 		$295K Buy
93,627
+364
+0.4% +$1.36K 0.01% 2820
2023
Q1 		$415K Buy
+93,263
New +$689K 0.01% 1859
2021
Q3 		– Sell
-4,947
Closed -$483 – 1581
2021
Q2 		$483 Sell
4,947
-977
-16% -$90.3K 0.02% 762
2021
Q1 		$604 Buy
5,924
+884
+18% +$103K 0.04% 486
2020
Q4 		$496 Buy
+5,040
New +$2.4M 0.04% 481

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return